Thank You for Reaching Out
Thank you for your interest in Vascular Perfusion Solutions and VP.S ENCORE®.
We look forward to connecting with you at ISHLT 2026 and sharing more about our work in advancing cardiac graft preservation through simplified hypothermic oxygenated machine perfusion technology.
A member of our team will be in touch shortly!
Guided by Research.
Built for Transplant Urgency.
VP.S ENCORE® is a hypothermic oxygenated machine perfusion device in development, built on over 100 preclinical heart perfusions and designed to extend donor heart viability up to 8 hours.
Developed in collaboration with transplant surgeons and medical institutions, the system reflects ongoing research focused on addressing time and logistical constraints in heart transplantation.
About Vascular Perfusion Solutions
Vascular Perfusion Solutions is a Texas-based MedTech company focused on advancing cardiac graft preservation through simplified hypothermic oxygenated machine perfusion technology.
The company takes a data-driven, evidence-based approach to research and development, working closely with leading scientists, engineers, and industry advisors to rigorously evaluate and refine its technology.
Its flagship system, VP.S ENCORE®, reflects this commitment to scientific integrity and practical innovation in cardiac transplantation.
Regulatory Note: VP.S ENCORE® is an investigational device, currently in development and not yet approved for commercial use by the FDA. Any features or descriptions shown are for informational purposes only.